Vahdat Sadaf, Mousavi Seyed Ahmad, Omrani Gholamreza, Gholampour Maziar, Sotoodehnejadnematalahi Fattah, Ghazizadeh Zaniar, Gharechahi Javad, Baharvand Hossein, Salekdeh Ghasem Hosseini, Aghdami Nasser
1Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
2Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran.
Stem Cells Dev. 2015 Jun 15;24(12):1390-404. doi: 10.1089/scd.2014.0222.
Cell therapy of heart diseases is emerging as one of the most promising known treatments in recent years. Transplantation of cardiac stem cells (CSCs) may be one of the best strategies to cure adult or pediatric heart diseases. As these patient-derived stem cells need to be isolated from small heart biopsies, it is important to select the best isolation method and CSC subpopulation with the best cardiogenic functionality. We employed three different protocols including c-KIT(+) cell sorting, clonogenic expansion, and explants culture to isolate c-KIT(+) cells, clonogenic expansion-derived cells (CEDCs), and cardiosphere-derived cells (CDCs), respectively. Evaluation of isolated CSC characteristics in vitro and after rat myocardial infarction (MI) model transplantation revealed that although c-KIT(+) and CDCs had higher MI regenerative potential, CEDCs had more commitment into cardiomyocytes and needed lower passages that were essential to reach a definite cell count. Furthermore, genome-wide expression analysis showed that subsequent passages caused changes in characteristics of cells, downregulation of cell cycle-related genes, and upregulation of differentiation and carcinogenic genes, which might lead to senescence, commitment, and possible tumorigenicity of the cells. Because of different properties of CSC subpopulations, we suggest that appropriate CSCs subpopulation should be chosen based on their experimental or clinical use.
近年来,心脏病的细胞疗法正成为最具前景的已知治疗方法之一。心脏干细胞(CSCs)移植可能是治疗成人或儿童心脏病的最佳策略之一。由于这些源自患者的干细胞需要从小的心脏活检组织中分离出来,因此选择最佳的分离方法和具有最佳心脏生成功能的CSC亚群非常重要。我们采用了三种不同的方案,包括c-KIT(+)细胞分选、克隆扩增和外植体培养,分别分离c-KIT(+)细胞、克隆扩增衍生细胞(CEDCs)和心球衍生细胞(CDCs)。对分离出的CSC特性进行体外评估以及在大鼠心肌梗死(MI)模型移植后的评估表明,虽然c-KIT(+)细胞和CDCs具有更高的MI再生潜力,但CEDCs向心肌细胞的分化能力更强,且达到确定细胞数量所需的传代次数更低。此外,全基因组表达分析表明,后续传代会导致细胞特性发生变化,细胞周期相关基因下调,分化和致癌基因上调,这可能导致细胞衰老、分化以及可能的致瘤性。由于CSC亚群具有不同的特性,我们建议应根据其实验或临床用途选择合适的CSC亚群。